Dublin, Feb. 02, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Wirelessly Enabled Injection Devices to 2022" report to their offering.

For self-administration, adherence with drug therapy and disease management protocols has become a primary concern within the healthcare and pharmaceutical industries. For chronic conditions adherence has a direct effect on the patient's quality-of-life.

Wirelessly enabled devices - drug injection devices that are designed to address the patient adherence issue by reminding and recording data about patient dosing activity and making it available to HCPs - are gaining interest among industry and managed care participants. Efforts to enhance adherence have a non-negligible effect on drug formulations and delivery decisions, and are a significant factor in the prescribing decisions of most physicians. The connected device ecosystem includes OEM device suppliers, drug developers, human factors consultants and aftermarket third-party devices.

Wirelessly Enabled Injection Devices - What You Will Learn

- What drug injection devices incorporate wireless connectivity technology, how do they work and what new capabilities do they offer to patients and their HCPs?
- What benefits do wirelessly enabled drug injectors provide to patients in the area of improved adherence? Patient reported outcomes? HCP/patient communication?
- What therapeutic areas are the current focus of wirelessly enabled devices?
- Who are the companies behind the growth of wirelessly enabled injection devices? What are their development activities and corporate alliances and affiliations
- What is the importance of pharma-device alliances and design partnerships on wirelessly enabled drug injection device commercialization and market access?
- What does the current market for wirelessly enabled drug injection devices look like? What will it look like in 2022?
- What are the key market drivers for the growth of wirelessly enabled injection devices?

Key Topics Covered:

1. Executive Summary

2. Wireless Injection Devices - The Opportunity

3. Injectable Device Technology

- Market Drivers
- The Growth of Self-Administration
- The Rise in Home Healthcare
- The Cost of Non-Adherence
- Biological Injectables and Patient Safety
- The Impact of Developing Economies

4. Connectivity Technologies

- Wireless Technologies
- Bluetooth
- Cellular
- Near Field Communications
- RFID

5. Wirelessly Enabled Device Classes

- Wearable Devices
- Handheld Devices
- Device Segments
- Non-drug Specific Connected Injectors
- Automated Connected Injectors
- Vendor-specific Connectivity Platforms
- Third Party Connectivity Devices

6. Near-term Markets for Connected Injection Devices

- Anaphylaxis
- Autoimmune Disease
- Cardiovascular
- Diabetes
- Hormone Replacement

7. Market Factors

- Regulatory Issues
- HIPAA and Patient Privacy
- Data Security
- Cybersecurity and Patient Safety
- Patient Safety
- User Training

8. Company Profiles

For more information about this report visit http://www.researchandmarkets.com/research/3zjs5t/wirelessly

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716
         Related Topics: Infusions and Injectables , Needles and Syringes 

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.